📖

cdkn2a

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-cdkn2a

Related Entities

Metadata

slug	genes-cdkn2a
entity_type	gene
kg_node_id	CDKN2A

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (161)

see_also📖APC Gene60%

see_also📖ARID1A60%

see_also📖ATM Gene60%

see_also📖BRAF — B-Raf Proto-Oncogene, Serine/Threonine Kinase60%

see_also📖DAPK1 Gene60%

see_also📖NRAS Gene60%

see_also📖PMS2 — DNA Mismatch Repair Protein PMS260%

see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%

see_also📖Apoptosis Pathway in Neurodegeneration60%

see_also📖DTI White Matter Changes in CBS/PSP60%

see_also📖Sleep Biomarkers for CBS and PSP60%

see_also📖Locus Coeruleus Noradrenergic in Progressive Supranuclear Pa60%

see_also📖Nigral Microglia in Progressive Supranuclear Palsy60%

see_also📖Pedunculopontine Nucleus Cholinergic in Progressive Supranuc60%

see_also📖Red Nucleus Psp60%

see_also📖Subthalamic Nucleus Neurons in Progressive Supranuclear Pals60%

see_also📖AMX0035 for Progressive Supranuclear Palsy60%

see_also📖BIIB080 (MAPTRx) ASO Therapy for PSP60%

see_also📖Davunetide (AL-108) PSP Trial60%

see_also📖First-in-Human 4R Tau Ligand Study in PSP60%

see_also📖FNP-223 PROSPER Trial - Phase 2 in Progressive Supranuclear 60%

see_also📖Gosuranemab (BIIB092) PSP Trial60%

see_also📖gv1001-psp60%

see_also📖Lithium Carbonate PSP Trial60%

see_also📖LY-3372689 LOTUS Trial - Phase 2 in Progressive Supranuclear60%

see_also📖NADAPT Study: NAD Replenishment Therapy for Atypical Parkins60%

see_also📖nct02605785-tau-pet-psp60%

see_also📖neflamapimod-psp60%

see_also📖NIO752 Tau ASO PSP Trial60%

see_also📖Syde® Digital Endpoints for PSP (NCT07389018)60%

see_also📖tetrabenazine-psp60%

see_also📖Tilavonemab PSP Trial Failure Analysis60%

see_also📖TPN-101 for Progressive Supranuclear Palsy60%

see_also📖Typhaneoside for Progressive Supranuclear Palsy60%

see_also📖UCB0107 for Progressive Supranuclear Palsy60%

see_also📖Eye Tracking and Saccade Testing in Progressive Supranuclear60%

see_also📖Metabolic Imaging and PET Tracers in CBS/PSP60%

see_also📖Neuropsychological Testing in CBS and PSP60%

see_also📖Polysomnography and Sleep Study Testing for Atypical Parkins60%

see_also📖Salivary Biomarkers in Corticobasal Syndrome60%

see_also📖transcranial-sonography-cbs-psp60%

see_also📖Whole Genome Sequencing for CBS/PSP60%

see_also📖Progressive Supranuclear Palsy (PSP)60%

see_also📖Apoptosis in Neurodegeneration60%

see_also📖PSP Rating Scale (PSPRS)60%

see_also📖Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%

see_also📖Brainstem Circuit Modulation for PSP60%

see_also📖CRISPR Gene Correction Approaches for CBS/PSP60%

see_also📖N-of-1 Clinical Trial Design for CBS/PSP60%

see_also📖ATRX — Alpha Thalassemia/Mental Retardation Syndrome X-Linke60%

see_also📖CAT — Catalase60%

see_also📖CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A60%

see_also📖COL4A1 Gene60%

see_also📖DCC60%

see_also📖DLC1 Gene - Deleted in Liver Cancer 160%

see_also📖EGR460%

see_also📖GLB1 Gene60%

see_also📖LZTS1 — Leucine Zipper Tumor Suppressor 160%

see_also📖MLH1 Gene60%

see_also📖NEUROG1 (Neurogenin-1)60%

see_also📖PALB2 Gene60%

see_also📖PDGFRA - Platelet Derived Growth Factor Receptor Alpha60%

see_also📖POT1 Gene60%

see_also📖PSP Gene - Persephin60%

see_also📖rab2360%

see_also📖SGCE — Sarcoglycan Epsilon60%

see_also📖SOX10 Gene60%

see_also📖WNT7A Gene60%

see_also📖Personalized Antisense Oligonucleotide (ASO) Therapy60%

see_also📖Axonal Transport Dysfunction in Progressive Supranuclear Pal60%

see_also📖Computational Models of Tau Propagation in Progressive Supra60%

see_also📖Computational Tau Spreading Models in Progressive Supranucle60%

see_also📖Exosome-Mediated Tau Propagation in Progressive Supranuclear60%

see_also📖Heat Shock Protein Dysfunction in Progressive Supranuclear P60%

see_also📖integrin-ecm-signaling-cbs-psp60%

see_also📖lipid-metabolism-psp60%

see_also📖Metabolomic Alterations in Progressive Supranuclear Palsy60%

see_also📖Neurotransmitter Dysfunction in Progressive Supranuclear Pal60%

see_also📖Oligodendroglial Involvement in Progressive Supranuclear Pal60%

see_also📖Ribosomal and Translation Dysfunction in Progressive Supranu60%

see_also📖Selective Neuronal Vulnerability in Progressive Supranuclear60%

see_also📖Vascular and Endothelial Dysfunction in Progressive Supranuc60%

see_also📖PSP Australia60%

see_also📖PSP Canada60%

see_also📖PSP France60%

see_also📖PSP Germany60%

see_also📖PSP Italy — Associazione Italiana PSP60%

see_also📖PSP Japan — 日本PSP協会60%

see_also📖PSP Netherlands — PSP Vereniging Nederland60%

see_also📖PSP Scandinavia60%

see_also📖PSP Spain — Asociación Española de PSP60%

see_also📖PSP Association UK60%

see_also📖PDGFRA — Platelet-Derived Growth Factor Receptor Alpha60%

see_also📖cognitive-reserve-cbs-psp60%

see_also📖combination-therapy-cbs-psp60%

see_also📖Hormone Neuroprotection in CBS/PSP60%

see_also📖pharmacogenomics-cbs-psp60%

see_also📖protective-strategies-cbs-psp60%

see_also📖section-155-art-therapy-creative-arts-therapies-cbs-psp60%

see_also📖section-181-advanced-music-rhythm-therapy-cbs-psp60%

see_also📖section-186-crispr-base-editing-therapeutics-cbs-psp60%

see_also📖section-197-advanced-clinical-trial-design-cbs-psp60%

see_also📖section-198-advanced-precision-medicine-implementation-cbs-p60%

see_also📖section-209-glp-1-receptor-agonists-cbs-psp60%

see_also📖section-228-advanced-dance-movement-therapy-cbs-psp60%

see_also📖section-239-advanced-light-therapy-photobiomodulation-cbs-ps60%

see_also📖section-242-advanced-stem-cell-therapy-neuronal-replacement-60%

see_also📖CACNA1G Gene60%

see_also📖bin160%

see_also📖DDX3X Gene60%

see_also📖GNA13 Gene60%

see_also📖KMT2A — lysine methyltransferase 2A60%

see_also📖MAP2K2 Gene60%

see_also📖PRKCB — Protein Kinase C Beta60%

see_also📖TSC1 — Tuberous Sclerosis Complex 160%

see_also📖MLL1 Histone H3K4 Methyltransferase (KMT2A)60%

see_also📖Autophagy Enhancement Drug Screening for Neurodegeneration60%

see_also📖CDK4 Gene60%

see_also📖FGF10 — Fibroblast Growth Factor 1060%

see_also📖KCNH1 Gene60%

see_also📖NCAM1 Gene60%

see_also📖PAK1 Gene60%

see_also📖RAB27A Gene60%

see_also📖RGS1 — Regulator of G Protein Signaling 160%

see_also📖SMAD4 — SMAD Family Member 460%

see_also📖TNC Gene60%

see_also📖KIF5B Gene60%

see_also📖KMT2D — Lysine Methyltransferase 2D60%

see_also📖MYO5A — Myosin Va60%

see_also📖NFKBIE Gene60%

see_also📖NSD2 (Nuclear Receptor Binding SET Domain Protein 2)60%

see_also📖RET Gene60%

see_also📖GLS - Glutaminase60%

see_also📖PRDM1 Gene60%

see_also📖REL Gene60%

see_also📖SLC31A2 — Solute Carrier Family 3 Member 1A2 (SLC31A2)60%

see_also📖CD19 Gene60%

see_also📖NSD3 (Nuclear Receptor Binding SET Domain Protein 3)60%

see_also📖SOX11 — SRY-Box Transcription Factor 1160%

mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%

mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%

mentions🧪Transcriptional Autophagy-Lysosome Coupling50%

mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%

mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%

mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%

mentions🧪Epigenetic Memory Erasure via TET2 Activation50%

mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

mentions🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬Epigenetic reprogramming in aging neurons50%

related🔬What are the mechanisms underlying epigenetic clocks and bio50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬Epigenetic reprogramming in aging neurons50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪KDM6A-Mediated H3K27me3 Rejuvenation40%

related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%

related🔬Gene expression changes in aging mouse brain predicting neur40%

mentions🔬What are the mechanisms underlying epigenetic clocks and bio35%

mentions🔬Epigenetic reprogramming in aging neurons35%